Literature DB >> 6603014

Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis.

M Sandberg-Wollheim.   

Abstract

The cerebrospinal fluid (CSF) and peripheral blood (PB) of patients with multiple sclerosis (MS), optic neuritis (ON), and aseptic meningitis (AM) were studied with respect to the percentage of B cells (using membrane Ig fluorescence), T cells, and T-cell subpopulations (using a rosetting technique or monoclonal antibodies). In the PB of all three patient groups there were normal B-cell levels but a significant decrease in T cells compared with PB of normal individuals. In the CSF the B cells were reduced but the T cells elevated when compared with the PB of the patients, and these differences were statistically significant. The level of total T cells was not influenced by disease activity in MS or ON, but there was a significant reduction of suppressor cells in PB during disease activity in MS patients. In CSF there were also fewer suppressor cells during active disease, but the reduction was not statistically significant. Differences in B and T cells in CSF and PB indicate that the immune reactions within the central nervous system are at least partially isolated from the rest of the immune system. The changes in the T-cell subpopulations in MS support the evidence for an immunoregulatory defect in this disease.

Entities:  

Mesh:

Year:  1983        PMID: 6603014     DOI: 10.1111/j.1365-3083.1983.tb00826.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

1.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

3.  Cerebrospinal fluid and peripheral blood T-lymphocyte subsets in multiple sclerosis: monoclonal antibody analysis and correlations with clinical activity.

Authors:  A Salmaggi; G Bianchi; D Cerrato; M Lazzaroni; L Malesani; A Nespolo; F Corridori; L La Mantia; C Milanese
Journal:  Ital J Neurol Sci       Date:  1987-08

4.  Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients.

Authors:  E C DeFreitas; M Sandberg-Wollheim; K Schonely; M Boufal; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

6.  Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

Authors:  R L Hirsch
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 7.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

Review 8.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

9.  Local and systemic immune response in multiple sclerosis: analysis of CSF inflammatory changes and peripheral blood T-cell subsets.

Authors:  A J Steck; J C de Flaugergues
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

10.  Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity.

Authors:  E I Gusev; T L Demina; A N Boiko; B V Pinegin
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.